| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 34.867 | 4.984 | 4.749 | 33.743 | 67.485 | 71.234 |
| Total Income - EUR | - | - | - | - | 34.867 | 4.984 | 4.749 | 33.743 | 67.485 | 71.234 |
| Total Expenses - EUR | - | - | - | - | 1.433 | 3.303 | 3.692 | 1.570 | 13.010 | 22.045 |
| Gross Profit/Loss - EUR | - | - | - | - | 33.434 | 1.681 | 1.058 | 32.173 | 54.475 | 49.189 |
| Net Profit/Loss - EUR | - | - | - | - | 32.388 | 1.529 | 1.021 | 31.222 | 53.800 | 46.982 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Laurmed Allergology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 375 | 1.291 | 1.030 | 932 | 23.810 | 17.315 |
| Current Assets | - | - | - | - | 32.316 | 280 | 1.583 | 32.125 | 32.628 | 41.103 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 423 | 27.290 | 4.388 | 30.548 |
| Cash | - | - | - | - | 32.316 | 280 | 1.160 | 4.834 | 28.240 | 10.555 |
| Shareholders Funds | - | - | - | - | 32.430 | 1.571 | 2.557 | 31.263 | 53.840 | 47.022 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 261 | 0 | 56 | 1.794 | 2.597 | 11.396 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Laurmed Allergology S.r.l.